Expanding insurance coverage, rising obesity prevalence and broader physician adoption are all contributing to the rapid mainstream acceptance of these therapies
The first GLP-1 analog (exenatide) was derived from the surprising source of Gila monster venom and approved in 2005 ( [3] ) ( [4] ), opening a new era of incretin mimetic therapy
This slowing of digestion, while beneficial for weight loss, can also lead to nausea, especially during the initial phase of treatment
Mass spectrometry is then used to verify molecular weight and structural accuracy
How to take retatrutide Retatrutide is expected to be a once-weekly injection that you can give yourself using a pen-style injector similar to existing GLP-1 medications
Historically, losing nearly a quarter of your body weight was an outcome reserved almost exclusively for Gastric Sleeve or Gastric Bypass surgery